What You Should Know: - Today, Alphabet’s Verily, a world leader in personalized medicine, and L’Oréal, the world leader in beauty, joined forces to lead a new era of precision skin health. - The first-of-its-kind partnership in the beauty industry aims to break down barriers to dermatology care and bring new insights to dermatologists that can help improve health outcomes for the nearly two billion people worldwide with skin issues. Strategic Partnership Addresses Unmet Need in
Read More
Verily
Verily, Sosei Heptares Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated Diseases
What You Should Know: - Verily and Sosei Heptares announced a new research collaboration combining Verily’s Immune Profiler platform, a next gen immune mapping platform, with Sosei Heptares’ world-leading StaR (stabilized receptor) platform, with the goal of rapidly identifying novel drug candidates across multiple immune-based disorders. - Together, the collaboration will focus on accelerating the development of new drug candidates against
Read More
Mayo Clinic, Verily Partner to Develop Clinical Decision Support Solutions
What You Should Know: - Today, Mayo Clinic and Verily, an Alphabet company announced a strategic two-year collaboration to develop clinical decision support solutions. This modular, evidence-based decision support solution, will provide contextualized and validated knowledge on disease management, care guidelines, and treatment to help clinicians make decisions. - The clinical decision support tool will be developed based on a broad range of health-relevant data sources, including
Read More
Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition
What You Should Know: Verily, an Alphabet company announced an agreement to acquire SignalPath, a Raleigh, NC-based clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. Financial details of the acquisition were not disclosed. - The acquisition marks Verily’s first major acquisition that will strengthen and expand Verily’s existing clinical trial system and evidence generation platform, known as Baseline. The
Read More
Colgate Taps Verily’s Baseline Platform for Oral Health Research
What You Should Know: - Verily and Colgate, today announce a new oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of the connections between oral health and overall human health. The study will assess how oral health practices affect health more broadly. - The study’s goal is to see how oral health practices, including intensive non-surgical periodontal therapy, as well as a robust Colgate home oral hygiene regimen monitored through
Read More
Morehouse College, Verily Announces $575k Endowed Life Sciences Scholarship to Support STEM Careers
- Today, Verily announced a partnership with Morehouse College in Atlanta, GA, to establish an endowed award of $575,000 to fund a new Verily Scholars Program. - The program will provide an annual scholarship to an exceptional Morehouse student majoring in STEM (Science, Technology, Mathematics, and Engineering) careers and will also fund up to three annual all-expenses paid summer internships at Verily. Verily looks forward to connecting Morehouse scholars to the biotech and
Read More
Highmark Health Taps Verily to Build Digital Health Tools for Living Health Model
What You Should Know: - Highmark Health has engaged Verily to build out digital health tools for patients and analytics solutions for Highmark’s clinicians as part of its Living Health model. This marks the first collaboration of its kind for Verily, Google Cloud and a partner. - Highmark Health is a Blue Cross Blue Shield health plan based in Western PA with 4.5 million members and an integrated delivery system (Allegheny) with 9
Read More
Verily and Janssen Launch COVID-19 Immune Response Study
What You Should Know: - Verily and Janssen launches COVID-19 Immune Response Study that aims to collect detailed information about how the coronavirus affects the immune system immediately after someone tests positive for COVID-19. Verily, an Alphabet company, is partnering with Janssen Research & Development LLC (Janssen) to launch a COVID-19 Immune Response Study as part of Verily’s Project Baseline. The study aims to collect detailed information about how the coronavirus affects
Read More
Verily’s Onduo Virtual Care Solution Expands to Multi-Condition Platform
What You Should Know: - Verily's Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to the right consumer at the right time. The expanded virtual care platform is designed to support patients managing type 2 diabetes and hypertension, with plans for further expansion into mental and behavioral health.- In addition, Onduo has introduced multi-language support to make the virtual
Read More
Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?
For many companies, 2020 has been a devastating year due to the consequences of the COVID-19 pandemic. While the same can be said for the digital health sector, the pandemic has also paved a way for unexpected and extraordinary business opportunities in 2021. Good ideas with a business loan from online lenders such as Biz2Credit are the ingredients for a successful business venture in this pandemic. In 2020, Digital health start-ups and more established companies have suffered, as have other
Read More
